1. Volume 380, Issue 9857, Pages 1927-1935 (December 2012)
Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial 
Prof Robert Pickard, MD, Thomas Lam, PhD, Graeme MacLennan, MSc, Kath Starr, BSc, Mary Kilonzo, MSc, Gladys McPherson, PhD, Katie Gillies, PhD, Alison McDonald, MSc, Katherine Walton, FRCPath, Brian Buckley, PhD, Prof Cathryn Glazener, PhD, Charles Boachie, MSc, Jennifer Burr, MSc, Prof John Norrie, MSc, Prof Luke Vale, PhD, Prof Adrian Grant, DM, Prof James N'Dow, MD 
The Lancet 
Volume 380, Issue 9857, Pages (December 2012)
DOI: /S (12)
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
Numbers of participants dying, declining further follow-up, or not responding are cumulative in direction of participant flow.
The Lancet  , DOI: ( /S (12) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2
Catheter-associated urinary tract infection up to 6 weeks after randomisation for the silver alloy catheter versus control (A) and nitrofural catheter versus control (B)
The Lancet  , DOI: ( /S (12) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

4. Figure 3
Observed and fitted incidence of catheter-associated urinary tract infection up to 6 weeks after randomisation versus duration of catheterisation
Data are n/N (%). n=number of participants with episode of CAUTI within 6 weeks of randomisation. N=number of participants with catheter duration of specified number of days. PTFE=polytetrafluoroethylene (control group). CAUTI=catheter-associated urinary tract infection.
The Lancet  , DOI: ( /S (12) )
Copyright © 2012 Elsevier Ltd Terms and Conditions